PCSKBIO Stock Latest News
Private CompaniesSK bioscience Targets RSV Antibody Market With Global Phase 1b Trial in Infants3M agoSKBIO
Private CompaniesOperational Focus On Vaccine Process Engineering At SK bioscience HQ3M agoSKBIO
Private CompaniesWHO GMP Review Underscores Regulatory Positioning for SK bioscience4M agoSKBIO
Private CompaniesSK bioscience – Weekly Recap5M agoSKBIO
Private CompaniesSK bioscience Licenses CDC Rotavirus Vaccine Technology to Target LMIC Growth Market5M agoSKBIO
Private CompaniesSK bioscience Deepens Global Vaccine Reach With UNICEF Deal and Colombian Tech Transfer5M agoSKBIO
Private CompaniesSK bioscience Secures UNICEF Role in 2026 Global Influenza Vaccination Programs5M agoSKBIO
Private CompaniesSK bioscience Wins UNICEF Contract to Supply 2026 Global Influenza Vaccines5M agoSKBIO
Private CompaniesSK bioscience Highlights Corporate Culture and R&D Hub at Songdo Family Event5M agoSKBIO
Private CompaniesSK bioscience Highlights People-First Culture at New Songdo Headquarters5M agoSKBIO
Private CompaniesKorea Growth Fund Backs SK bioscience’s Late-Stage Pneumococcal Vaccine Program5M agoSKBIO
Private CompaniesSK bioscience Emphasizes Preventive Health Through Chickenpox Awareness Initiative5M agoSKBIO
Private CompaniesSK bioscience Emphasizes Chickenpox Awareness and Vaccination in Public Health Outreach5M agoSKBIO
Private CompaniesSK bioscience Targets Latin American Growth With VECOL Vaccine Collaboration5M agoSKBIO
Private CompaniesSK bioscience Secures $260 Million Colombian Vaccine Platform as LATAM Entry Hub5M agoSKBIO

